Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis

NCT: NCT05367505 · RECRUITING

NCT IDNCT05367505
StatusRECRUITING
Start Date2023-01-09
Completion2026-12-01

Brief Summary

Many approaches to the surgical treatment of OF-P have been tried, but no one method has stood out as particularly successful. The placement of three implants, including implants that could minimise motion in the sacroiliac joint through early fixation and long-term fusion of the sacroiliac joint, can prevent micromotion in the fracture and thereby improve the clinical outcome of OF-Ps. The iFuse-3D implant was shown to be safe and effective for chronic sacroiliac pain in non-osteoporotic patients. The primary aim is to assess the proportion of patients operated on using iFuse-3D in conjunction with transiliac-transsacral screws who regain pre-fracture mobility by the time of hospital discharge.

Frequently Asked Questions

What is Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis?

Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis is a clinical trial registered under NCT05367505. Current status: RECRUITING.

What is the status of NCT05367505?

The current status of NCT05367505 (Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis) is: RECRUITING.

When did Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis start?

Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis started on 2023-01-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.